Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cara Haymaker

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Cancer Immunology Research|March 28, 2020
Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8<sup>+</sup> T Cells to Memory T CellsJunmei Wang, Farah Hasan, Amanda C Frey, et al.
Oncoimmunology|April 9, 2016
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacityMarie-Andrée Forget, Cara Haymaker, Jennifer B Dennison, et al.
Journal for Immunotherapy of Cancer|January 25, 2017
Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
Scientific Reports|April 20, 2021
Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissueEdwin Roger Parra, Maria C Ferrufino-Schmidt, Auriole Tamegnon, et al.
Journal for Immunotherapy of Cancer|September 24, 2016
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
The Lancet. Oncology|April 12, 2024
Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trialMatthew T Campbell, Vania Balderrama-Brondani, Camilo Jimenez, et al.
Nature Communications|May 15, 2023
Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancerEdwin Roger Parra, Jiexin Zhang, Mei Jiang, et al.
Cancers|January 25, 2020
Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology StudiesEdwin Roger Parra, Mei Jiang, Luisa Solis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 12, 2014
Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanomaMarie-Andrée Forget, Shruti Malu, Hui Liu, et al.
Arxiv|September 5, 2025
The Next Layer: Augmenting Foundation Models with Structure-Preserving and Attention-Guided Learning for Local Patches to Global Context Awareness in Computational PathologyMuhammad Waqas, Rukhmini Bandyopadhyay, Eman Showkatian, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Cancer Immunology Research|March 28, 2020
Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8<sup>+</sup> T Cells to Memory T CellsJunmei Wang, Farah Hasan, Amanda C Frey, et al.
Oncoimmunology|April 9, 2016
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacityMarie-Andrée Forget, Cara Haymaker, Jennifer B Dennison, et al.
Journal for Immunotherapy of Cancer|January 25, 2017
Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
Scientific Reports|April 20, 2021
Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissueEdwin Roger Parra, Maria C Ferrufino-Schmidt, Auriole Tamegnon, et al.
Journal for Immunotherapy of Cancer|September 24, 2016
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.
The Lancet. Oncology|April 12, 2024
Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trialMatthew T Campbell, Vania Balderrama-Brondani, Camilo Jimenez, et al.
Nature Communications|May 15, 2023
Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancerEdwin Roger Parra, Jiexin Zhang, Mei Jiang, et al.
Cancers|January 25, 2020
Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology StudiesEdwin Roger Parra, Mei Jiang, Luisa Solis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 12, 2014
Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanomaMarie-Andrée Forget, Shruti Malu, Hui Liu, et al.
Arxiv|September 5, 2025
The Next Layer: Augmenting Foundation Models with Structure-Preserving and Attention-Guided Learning for Local Patches to Global Context Awareness in Computational PathologyMuhammad Waqas, Rukhmini Bandyopadhyay, Eman Showkatian, et al.
Pageof 11